Toll-like receptor 3 polymorphism and its association with hepatitis B virus infection in Saudi Arabian patients

Journal of Medical Virology

Volumn 84, Issue 9, 2012, Pages 1353-1359

  Al Qahtani, Ahmed ^a,b   Al Ahdal, Mohammed ^a   Abdo, Ayman ^b,c   Sanai, Faisal ^b,d   Al Anazi, Mashael ^a   Khalaf, Nisreen ^a   Viswan, Nisha A ^a   Al Ashgar, Hamad ^a   Al Humaidan, Hind ^a   Al Suwayeh, Riham ^a   Hussain, Zahid ^b   Alarifi, Saud ^b,e   Al Okail, Majid ^b,e   Almajhdi, Fahad N ^b,e  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

^d KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^e KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Disease progression; Hepatitis B virus; Saudi Arabian population; Single nucleotide polymorphism; TLR3

Indexed keywords

ALPHA FETOPROTEIN; TOLL LIKE RECEPTOR 3;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA SEQUENCE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HEPATITIS B; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; SAUDI ARABIA; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; VIRUS LOAD;

ADULT; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; HAPLOTYPES; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SAUDI ARABIA; SEQUENCE ANALYSIS, DNA; TOLL-LIKE RECEPTOR 3; VIRAL LOAD;

HEPATITIS B VIRUS;

EID: 84864122520     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23271     Document Type: Article

References (37)

1. Akira S, Uematsu S, Takeuchi O. 2006. Pathogen recognition and innate immunity. Cell 124: 783-801.
2. Askar E, Bregadze R, Mertens J, Schweyer S, Rosenberger A, Ramadori G, Mihm S. 2009. TLR3 gene polymorphisms and liver disease manifestations in chronic hepatitis C. J Med Virol 81: 1204-1211.
3. Bertolino P, Holz LE. 2007. Toll-like receptor-3 and the regulation of intrahepatic immunity: Implications for interferon-alpha therapy. Hepatology 45: 250-251.
4. Duluc D, Tan F, Scotet M, Blanchard S, Frémaux I, Garo E, Horvat B, Eid P, Delneste Y, Jeannin P. 2009. PolyI:C plus IL-2 or IL-12 induce IFN-gamma production by human NK cells via autocrine IFN-beta. Eur J Immunol 39: 2877-2884.
5. Farrell J, Dienstag J. 2002. Epidemiology and prevention of hepatitis B virus infection. In: Lai CL, Locarnini S, editors. Hepatitis B virus. London, UK: International Medical Press, pp 115-130.
6. He JF, Jia WH, Fan Q, Zhou XX, Qin HD, Shugart YY, Zeng YX. 2007. Genetic polymorphisms of TLR3 are associated with Nasopharyngeal carcinoma risk in Cantonese population. BMC Cancer 7: 194.
7. Hidaka F, Matsuo S, Muta T, Takeshige K, Mizukami T, Nunoi H. 2006. A missense mutation of the Toll-like receptor 3 gene in a patient with influenza-associated encephalopathy. Clin Immunol 119: 188-194.
8. Hwang YH, Ro H, Choi I, Kim H, Oh KH, Hwang JI, Park MH, Kim S, Yang J, Ahn C. 2009. Impact of polymorphisms of TLR4/CD14 and TLR3 on acute rejection in kidney transplantation. Transplantation 88: 699-705.
9. Isogawa M, Robek MD, Furuichi Y, Chisari FV. 2005. Toll-like receptor signaling inhibits hepatitis B virus replication in vivo. J Virol 79: 7269-7272.
10. Jung M, Pape G. 2002. Immunology of hepatitis B infection. Lancet Infect Dis 2: 43-50.
11. Kanda T, Steele R, Ray R, Ray RB. 2007. Hepatitis C virus infection induces the beta interferon signaling pathway in immortalized human hepatocytes. J Virol 81: 12375-12381.
12. Kariko K, Ni H, Capodici J, Lamphier M, Weissman D. 2004. mRNA is an endogenous ligand for Toll-like receptor 3. J Biol Chem 279: 12542-12550.
13. Krüger B, Banas MC, Walberer A, Böger CA, Farkas S, Hoffmann U, Fischereder M, Banas B, Krämer BK. 2010. A comprehensive genotype-phenotype interaction of different Toll-like receptor variations in a renal transplant cohort. Clin Sci (Lond) 119: 535-544.
14. Lang KS, Georgiev P, Recher M, Navarini AA, Bergthaler A, Heikenwalder M, Harris NL, Junt T, Odermatt B, Clavien PA, Pircher H, Akira S, Hengartner H, Zinkernagel RM. 2006. Immunoprivileged status of the liver is controlled by Toll-like receptor 3 signaling. J Clin Invest 116: 2456-2463.
15. Li N, Li Q, Qian Z, Zhang Y, Chen M, Shi G. 2009. Impaired TLR3/IFN-beta signaling in monocyte-derived dendritic cells from patients with acute-on-chronic hepatitis B liver failure: Relevance to the severity of liver damage. Biochem Biophys Res Commun 390: 630-635.
16. Lund JM, Alexopoulou L, Sato A, Karow M, Adams NC, Gale NW, Iwasaki A, Flavell RA. 2004. Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc Natl Acad Sci USA 101: 5598-5603.
17. Marshak-Rothstein A. 2006. Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol 6: 823-835.
18. Matsumoto M, Oshiumi H, Seya T. 2011. Antiviral responses induced by the TLR3 pathway. Rev Med Virol 21: 67-77.
19. Medzhitov R, Preston-Hurlburt P, Janeway CA Jr. 1997. A human homologue of the Drosophila toll protein signals activation of adaptive immunity. Nature 388: 394-397.
20. Mencin A, Kluwe J, Schwabe RF. 2009. Toll-like receptors as targets in chronic liver diseases. Gut 58: 704-720.
21. Miyakawa Y, Mizokami M. 2003. Classifying hepatitis B virus genotypes. Intervirology 46: 329-338.
22. Perrin-Cocon L, Agaugué S, Diaz O, Vanbervliet B, Dollet S, Guironnet-Paquet A, André P, Lotteau V. 2008. Th1 disabled function in response to TLR4 stimulation of monocyte-derived DC from patients chronically-infected by hepatitis C virus. PLoS ONE 3: e2260.
23. Pirie FJ, Pegoraro R, Motala AA, Rauff S, Rom L, Govender T, Esterhuizen TM. 2005. Toll-like receptor 3 gene polymorphisms in South African Blacks with type 1 diabetes. Tissue Antigens 66: 125-130.
24. Riordan SM, Skinner N, Kurtovic J, Locarnini S, Visvanathan K. 2006a. Reduced expression of toll-like receptor 2 on peripheral monocytes in patients with chronic hepatitis B. Clin Vaccine Immunol 13: 972-974.
25. Riordan SM, Skinner NA, Kurtovic J, Locarnini S, McIver CJ, Williams R, Visvanathan K. 2006b. Toll-like receptor expression in chronic hepatitis C: Correlation with pro-inflammatory cytokine levels and liver injury. Inflamm Res 55: 279-285.
26. Sanai FM, Helmy A, Bzeizi KI, Babatin MA, Al-Qahtani A, Al-Ashgar HA, Al-Mdani AS, Al-Akwaa A, Almutharea S, Khan MQ, Alghamdi AS, Farah T, Al-Hamoudi W, Saadeh M, Abdo AA. 2011. Discriminant value of serum HBV DNA levels as predictors of liver fibrosis in chronic hepatitis B. J Viral Hepat 18: e217-e225.
27. Schröder M, Bowie AG. 2005. TLR3 in antiviral immunity: Key player or bystander? Trends Immunol 26: 462-468.
28. Seegar C, Mason WS. 2000. Hepatitis B virus biology. Microbiol Mol Biol Rev 64: 51-68.
29. Seki E, Brenner DA. 2008. Toll-like receptors and adaptor molecules in liver disease: Update. Hepatology 48: 322-335.
30. Stuyver L, De Gendt S, Van Geyt C, Zoulim F, Fried M, Schinazi RF, Rossau R. 2000. A new genotype of hepatitis B virus: Complete genome and phylogenetic relatedness. J Gen Virol 81: 67-74.
31. Summers J, O'Connell A, Millman I. 1975. Genome of hepatitis B virus: Restriction enzyme cleavage and structure of DNA extracted from Dane particles. Proc Natl Acad Sci USA 72: 4597-4601.
32. Takii Y, Nakamura M, Ito M, Yokoyama T, Komori A, Shimizu-Yoshida Y, Nakao R, Kusumoto K, Nagaoka S, Yano K, Abiru S, Ueki T, Matsumoto T, Daikoku M, Taniguchi K, Fujioka H, Migita K, Yatsuhashi H, Nakashima M, Harada M, Ishibashi H. 2005. Enhanced expression of type I interferon and toll-like receptor-3 in primary biliary cirrhosis. Lab Invest 85: 908-920.
33. Ueta M, Sotozono C, Inatomi T, Kojima K, Tashiro K, Hamuro J, Kinoshita S. 2007. Toll-like receptor 3 gene polymorphisms in Japanese patients with Stevens-Johnson syndrome. Br J Ophthalmol 91: 962-965.
34. Wang B, Trippler M, Pei R, Lu M, Broering R, Gerken G, Schlaak JF. 2009. Toll-like receptor activated human and murine hepatic stellate cells are potent regulators of hepatitis C virus replication. J Hepatol 51: 1037-1045.
35. WHO. 2000. WHO fact sheets on hepatitis B. .
36. Wu J, Lu M, Meng Z, Trippler M, Broering R, Szczeponek A, Krux F, Dittmer U, Roggendorf M, Gerken G, Schlaak JF. 2007. Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice. Hepatology 46: 1769-1778.
37. Yu S, Chen J, Wu M, Chen H, Kato N, Yuan Z. 2010. Hepatitis B virus polymerase inhibits RIG-I- and Toll-like receptor 3-mediated beta interferon induction in human hepatocytes through interference with interferon regulatory factor 3 activation and dampening of the interaction between TBK1/IKKepsilon and DDX3. J Gen Virol 91: 2080-2090.